Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration

•Retinal fluid and vision outcomes were assessed in patients with neovascular age-related macular degeneration who were treated with ranibizumab.•Vision gains were greater in eyes with residual vs resolved subretinal fluid.•Vision gains were lower in eyes with residual vs resolved intraretinal fluid.•Fluid–vision relationships are more complex than determining a wet or dry macula.